Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (27775)	2/3/1999 9:19:00 AM
From: ouija	Read Replies (1) \| Respond to of 32384

Don't forget the takeover rumour...something due this weekend supposedly...I personally don't know what is behind the rumour but there is no question a lot of consolidation is taking place in Biotech...if I was in a position to do so, LGND would be a tasty morsel which could have many pieces sold off...has too many irons in the fire now

To: Henry Niman who wrote (27775)	2/3/1999 9:22:00 AM
From: Alper H.YUKSEL	Respond to of 32384

<< Bringing a drug from discovery to the pharmacy shelf in 7 years is quite a accomplishment and LGND employees should be quite proud of such a feat. >> I certainly agree with the above and I also believe that it is very significant, as it is the validation of LGND's technology platform as well as its management. I still think that this will not drive us to 13+. My guess is, we'll see some activity with the start of the session, which will fade away later on. Regards

To: Henry Niman who wrote (27775)	2/3/1999 9:23:00 AM
From: Alper H.YUKSEL	Read Replies (2) \| Respond to of 32384

As of 9:20 12 7/16 x 12 1/2

To: Henry Niman who wrote (27775)	2/3/1999 1:41:00 PM
From: Cheryl Galt	Read Replies (1) \| Respond to of 32384

Henry, Bringing a drug from discovery to the pharmacy shelf in 7 years IS quite an accomplishment, and LGND employees and shareholders ARE proud of such a feat. I'm sure Ron Evans feels particularly pleased at this moment. I'm sure this a big day for you too, Henry, and I can understand your excitement. You've even told the Cisco thread about the news! ;-) Why not!! <VBG> I'm happy that this one came in ahead of Seragen's drug. I never anticipated any long-term price pop because of this news (and this doesn't bother me -- a vastly more significant event will hopefully happen this year). The street isn't deaf, dumb, and blind -- and so the Panretin Gel news has long been built into the price, imo. And the Street knows the difference between a gel and a systemic drug. I do guess that this success will dampen some of the stock's price volatility. The "nonsense on the thread" never intimated problems with this drug. Rather, contrarians objected to what seemed to be overly optimistic predictions of the stock's early price appreciation due to the drug, and over confidence that flurries of analyst reports and stock-promoter blurbs (eg Murphy, Individual Investor) would drive up (and sustain) the price. The "nonsense" folks are merely trying to caution regulars and newbies (and themselves <ng> ) -- during times giddy with "the sweet smell of hype" (great image, Bob!) -- that it's better to buy low and sell high, than the reverse. In my view, one of the biggest plusses from this milestone: Ligand now has under its belt experience in navigating complicated dealings with the FDA -- experience invaluable for efficiently promoting its future, more important filings. Happy day, Henry! Regards, Cheryl